Third-Generation PCSK9 Inhibitor Approved for High Cholesterol

By News Health
18 minutes Ago

(MedPage Today) — The FDA approved lerodalcibep (Lerochol) injections for the treatment of elevated LDL cholesterol in adults, maker LIB Therapeutics announced.
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet…

Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/119050

Author :

Publish date : 2025-12-16 20:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cardiologist Found Dead; Biological Aging and CVD Risk; New Coronary Clot Retriever

California Hires Ex-CDC Leaders Who Were Fired or Quit Under Trump

Ministers Promise Urgent Care Focus in NHS Dental Reform

Wound Care Scheme Yields Long Prison Sentences

Bispecific Antibody Induces High Response Rate in Metastatic TNBC

AI Model Stratifies Late Recurrence Risk in HR-Positive Breast Cancer